| Literature DB >> 27021092 |
A A Ozerov1, V V Bagmetova2, Yu V Chernysheva1, I N Tyurenkov1.
Abstract
A new (aryloxyalkyl)adenine derivative Adeprophen (9-[2-(4-isopropylphenoxy)ethyl]adenine, VMA-99-82) has a strong antidepressant effect on the model of reserpine-induced depression in rats (single dose 4 mg/kg, intraperitoneally). This effect manifested in suppression of depression-like behavior in the Porsolt forced swimming test (shortening of immobility time and increase in immobility latency, number of jumping episodes, and time of active swimming) and sucrose consumption/preference test (increase in the consumption of 20% sucrose solution in g/100 g body weight and percentage of sucrose preference in relation to the total fluid preference). Adeprophen had a greater antidepressant effect than sertraline and fluoxetine, but was less potent than amitriptyline, imipramine, venlafaxine, and to a lesser extent to paroxetine.Entities:
Keywords: (aryloxyalkyl)adenine derivatives; adeprophen (VMA-99-82); antidepressants; reserpine-induced depression
Mesh:
Substances:
Year: 2016 PMID: 27021092 DOI: 10.1007/s10517-016-3240-6
Source DB: PubMed Journal: Bull Exp Biol Med ISSN: 0007-4888 Impact factor: 0.804